We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MDxHealth, Cerba HealthCare Announce Collaboration

News   Jul 26, 2016

 
MDxHealth, Cerba HealthCare Announce Collaboration
 
 
 

RELATED ARTICLES

Hindering Melanoma Metastasis with FDA-approved Drug

News

An FDA-approved drug has been identified that, when used with surgery, hampers metastasis in an animal model. Originally developed and approved ~65 years ago to control blood pressure, the medication resperine also prevents what are known as tumor-derived extracellular vesicles from fusing to healthy cells and sharing their cargo of disease-promoting molecules.

READ MORE

Altering Stathmin2 Expression Rescues Motor Neuron Growth

News

Research led by stem cell scientists at Harvard University points to a potential new biomarker and drug target for amyotrophic lateral sclerosis (ALS), a neurological disease that is difficult to diagnose and treat.

READ MORE

Blood-brain Barrier Breakdown Early Marker of Human Cognitive Dysfunction

News

Individuals with early cognitive function develop brain capillary damage and blood-brain barrier breakdown in the hippocampus, regardless of amyloid beta/tau biomarker changes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE